Giacomo Chiesi

Bio:

A lifelong advocate for patients, Giacomo Chiesi serves as Executive Vice President of Chiesi Global Rare Diseases, where he leads efforts to develop and deliver transformative therapies for individuals living with rare and ultra-rare conditions. With a mission to listen deeply, act boldly, and alleviate suffering, Giacomo is focused on building an organization that centers the voices of patients at every stage of innovation.

Previously, he led Global Corporate Development for the Chiesi Group, where his strategic vision helped expand Chiesi into new markets across North America, Europe, and Asia and laid the foundation for the launch of the rare disease business unit.

He is also Managing Partner of Chiesi Ventures, a joint venture with Pappas Capital, focused on starting new rare disease companies. Giacomo serves on the Chiesi Group Board of Directors and on the Advisory Board of the Orphan Therapeutics Accelerator, a non-profit biotech organization focused on completing development and commercializing therapies for ultra-rare conditions. A Champion of Hope awardee and PharmaVoice 100 Honoree, Giacomo remains committed to shaping a future where all patients feel heard, seen, and supported.